These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6325019

  • 1. Antagonism of calmodulin and phosphodiesterase by nifedipine and related calcium entry blockers.
    Minocherhomjee AE, Roufogalis BD.
    Cell Calcium; 1984 Feb; 5(1):57-63. PubMed ID: 6325019
    [Abstract] [Full Text] [Related]

  • 2. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM, Cysouw KJ, Verdouw PD.
    Biochem Pharmacol; 1985 Nov 01; 34(21):3837-43. PubMed ID: 2933041
    [Abstract] [Full Text] [Related]

  • 3. Dihydropyridine Ca2+ entry blockers selectively inhibit peak I cAMP phosphodiesterase.
    Norman JA, Ansell J, Phillips MA.
    Eur J Pharmacol; 1983 Sep 16; 93(1-2):107-12. PubMed ID: 6313398
    [Abstract] [Full Text] [Related]

  • 4. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
    Walsh MP, Sutherland C, Scott-Woo GC.
    Biochem Pharmacol; 1988 Apr 15; 37(8):1569-80. PubMed ID: 2833901
    [Abstract] [Full Text] [Related]

  • 5. Differences in Ca2+ entry blockers revealed by effects on adenosine- and adrenergic- receptors and cyclic AMP levels of [2-3H]adenine-prelabeled vesicles prepared from guinea pig brain.
    Psychoyos S, Bax M, Atkins C.
    Biochem Pharmacol; 1986 May 15; 35(10):1639-46. PubMed ID: 3011009
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of turkey gizzard myosin light chain kinase activity by BAY K 8644.
    Movsesian MA, Adelstein RS.
    Eur J Pharmacol; 1984 Aug 03; 103(1-2):161-3. PubMed ID: 6207034
    [Abstract] [Full Text] [Related]

  • 7. Calcium antagonists and calmodulin: effect of verapamil, nifedipine and diltiazem.
    Daly MJ, Perry S, Nayler WG.
    Eur J Pharmacol; 1983 May 20; 90(1):103-8. PubMed ID: 6307716
    [Abstract] [Full Text] [Related]

  • 8. Effects of felodipine, nitrendipine and W-7 on arterial myosin phosphorylation, actin-myosin interactions and contraction.
    Silver PJ, Ambrose JM, Michalak RJ, Dachiw J.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):417-24. PubMed ID: 6489434
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists.
    Sharma RK, Wang JH, Wu Z.
    J Neurochem; 1997 Aug 20; 69(2):845-50. PubMed ID: 9231746
    [Abstract] [Full Text] [Related]

  • 10. Interaction of smooth muscle relaxant drugs with calmodulin and cyclic nucleotide phosphodiesterase.
    Ronca-Testoni S, Hrelia S, Hakim G, Rossi CA.
    Experientia; 1985 Jan 15; 41(1):75-6. PubMed ID: 2981701
    [Abstract] [Full Text] [Related]

  • 11. Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta.
    Ivorra MD, Lugnier C, Catret M, Anselmi E, Cortes D, D'Ocon P.
    Br J Pharmacol; 1993 Jun 15; 109(2):502-9. PubMed ID: 8358549
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of erythrocyte membrane Ca(2+)-pumping ATPase of hypertensive humans by nifedipine, a calcium entry blocker.
    Olorunsogo OO, Onatola OO, Lawal SO, Bababunmi EA, Falase AO, Okunade WG.
    Afr J Med Med Sci; 1991 Mar 15; 20(1):61-5. PubMed ID: 1829316
    [Abstract] [Full Text] [Related]

  • 13. Nitrendipine, nifedipine and verapamil inhibit the in vitro formation of irreversibly sickled cells.
    Ohnishi ST, Horiuchi KY, Horiuchi K, Jurman ME, Sadanaga KK.
    Pharmacology; 1986 Mar 15; 32(5):248-56. PubMed ID: 2940606
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of calmodulin-dependent cyclic nucleotide phosphodiesterase by flunarizine, a calcium-entry blocker.
    Kubo K, Matsuda Y, Kase H, Yamada K.
    Biochem Biophys Res Commun; 1984 Oct 30; 124(2):315-21. PubMed ID: 6093793
    [Abstract] [Full Text] [Related]

  • 15. Activation of protein kinase C by the dihydropyridine calcium channel blocker, felodipine.
    Sutherland C, Walsh MP.
    Biochem Pharmacol; 1989 Apr 15; 38(8):1263-70. PubMed ID: 2706018
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of turkey gizzard myosin light chain. Kinase activity by dihydropyridine calcium antagonists.
    Movsesian MA, Swain AL, Adelstein RS.
    Biochem Pharmacol; 1984 Dec 01; 33(23):3759-64. PubMed ID: 6548915
    [Abstract] [Full Text] [Related]

  • 17. Different sensitivities of Ca2+, calmodulin-dependent cyclic nucleotide phosphodiesterases from rabbit aorta and brain to dihydropyridine calcium channel blockers.
    Matsushima S, Tanaka T, Saitoh M, Watanabe M, Hidaka H.
    Biochem Biophys Res Commun; 1987 Nov 13; 148(3):1468-74. PubMed ID: 2825687
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of canine cardiac sarcoplasmic reticulum Ca2+ uptake by dihydropyridine Ca2+ antagonists.
    Movsesian MA, Ambudkar IS, Adelstein RS, Shamoo AE.
    Biochem Pharmacol; 1985 Jan 15; 34(2):195-201. PubMed ID: 3155615
    [Abstract] [Full Text] [Related]

  • 19. Effect of nifedipine on cyclic GMP turnover in cultured coronary smooth muscle cells.
    Kishi Y, Watanabe T, Makita T, Sakita S, Watanabe R, Ashikaga T, Numano F.
    J Cardiovasc Pharmacol; 1995 Oct 15; 26(4):590-5. PubMed ID: 8569220
    [Abstract] [Full Text] [Related]

  • 20. Nifedipine blocks Ca2+ store refilling through a pathway not involving L-type Ca2+ channels in rabbit arteriolar smooth muscle.
    Curtis TM, Scholfield CN.
    J Physiol; 2001 May 01; 532(Pt 3):609-23. PubMed ID: 11313433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.